Pediatric Psoriasis
Tolliver S, Pepper A, Pothiawala S, Silverberg N. Pediatric Psoriasis. 2020, 311-342. DOI: 10.1007/978-3-030-54859-9_25.Peer-Reviewed Original ResearchPediatric psoriasisInfectious triggerMid-potency topical corticosteroidsMulti-system inflammatory conditionBroadening treatment optionsMinimization of side effectsPoor quality of lifeDisease clearanceTopical corticosteroidsNarrowband UVBAdult psoriasisWaist circumferencePityriasis amiantaceaTreatment optionsAutoimmune componentQuality of lifeSystemic agentsPsoriatic diseaseInflammatory conditionsKoebner phenomenonSide effectsGeneralized diseasePsoriasisSevere casesPrescription careExploring outcomes and characteristics of myasthenia gravis: Rationale, aims and design of registry – The EXPLORE-MG registry
Anil R, Kumar A, Alaparthi S, Sharma A, Nye JL, Roy B, O'Connor KC, Nowak RJ. Exploring outcomes and characteristics of myasthenia gravis: Rationale, aims and design of registry – The EXPLORE-MG registry. Journal Of The Neurological Sciences 2020, 414: 116830. PMID: 32388060, DOI: 10.1016/j.jns.2020.116830.Peer-Reviewed Original ResearchConceptsMyasthenia gravisMG patientsContemporary patient cohortKey clinical featuresMuscle-specific kinaseMG clinicClinical featuresGeneralized diseaseOutcomes RegistryPatient cohortPatient outcomesTreatment responsivenessTreatment outcomesTreatment strategiesRegistry dataEpidemiological dataInterim analysisData registryOcular diseasesPatientsCommon data elementsAcetylcholine receptorsRegistryPatient careDisease
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply